Background Evidence-based treatment for hypercholesterolaemia in Japan has been hindered by the lack of direct evidence in this population. Our aim was to assess whether evidence for treatment with statins derived from western populations can be extrapolated to the Japanese population. ## Methods
β¦ LIBER β¦
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
β Scribed by Haruo Nakamura; Kikuo Arakawa; Hiroshige Itakura; Akira Kitabatake; Yoshio Goto; Takayoshi Toyota; Noriaki Nakaya; Shoji Nishimoto; Masaharu Muranaka; Akira Yamamoto; Kyoichi Mizuno; Yasuo Ohashi
- Book ID
- 117299984
- Publisher
- The Lancet
- Year
- 2006
- Tongue
- English
- Weight
- 183 KB
- Volume
- 368
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Primary prevention of cardiovascular dis
β
Haruo Nakamura; Kikuo Arakawa; Hiroshige Itakura; Akira Kitabatake; Yoshio Goto;
π
Article
π
2006
π
The Lancet
π
English
β 183 KB
Probiotics in primary prevention of atop
β
Marko KalliomΓ€ki; Seppo Salminen; Heikki Arvilommi; Pentti Kero; Pertti Koskinen
π
Article
π
2001
π
The Lancet
π
English
β 89 KB
Secondary prevention with antioxidants o
β
M Boaz; S Smetana; T Weinstein; Z Matas; U Gafter; A Iaina; A Knecht; Y Weissgar
π
Article
π
2000
π
The Lancet
π
English
β 96 KB
Primary prevention of cardiovascular dis
β
H.M. Colhoun; D.J. Betteridge; P.N. Durrington
π
Article
π
2004
π
Elsevier Science
π
English
β 37 KB
Primary prevention of cardiovascular dis
β
Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew
π
Article
π
2004
π
The Lancet
π
English
β 199 KB
Primary prevention of cardiovascular dis
β
Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew
π
Article
π
2004
π
The Lancet
π
English
β 199 KB
Background Type 2 diabetes is associated with a substantially increased risk of cardiovascular disease, but the role of lipid-lowering therapy with statins for the primary prevention of cardiovascular disease in diabetes is inadequately defined. We aimed to assess the effectiveness of atorvastatin 1